• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在低反应者体外受精中使用高剂量人卵泡刺激素和人绝经期促性腺激素的激发方案

Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.

作者信息

Padilla S L, Dugan K, Maruschak V, Shalika S, Smith R D

机构信息

Fertility Center of Maryland, Baltimore, USA.

出版信息

Fertil Steril. 1996 Apr;65(4):796-9. doi: 10.1016/s0015-0282(16)58216-8.

DOI:10.1016/s0015-0282(16)58216-8
PMID:8654641
Abstract

OBJECTIVE

To analyze the effect of high dose human FSH in combination with hMG with a flare-up leuprolide acetate (LA) protocol in patients undergoing IVF at risk for a poor response.

DESIGN

Prospective.

SETTING

Free-standing ambulatory IVF center.

PATIENTS

Two hundred eighty-four patients underwent a LA screening test for IVF. Patients with a lack of flare response were considered at risk for a poor response and underwent ovarian stimulation with the flare-up LA protocol in combination with high dose human FSH and hMG.

RESULTS

The poor responder group was compared with the good responders on the flare-up LA protocol and to patients undergoing ovulation induction with a luteal phase LA protocol. There were 53 poor responder flare-up LA cycles, 177 good responder flare-up LA cycles, and 54 luteal phase LA cycles. The cancellation rate was higher in poor flare-up LA responders (11.3 percent) compared with good flare-up LA responders (1.1 percent) and luteal phase LA cycles (1.8 percent). Peak E2 levels, number of oocytes, and number of embryos were significantly higher in the good flare-up LA responders. Fertilization rate was similar in all groups. Ongoing pregnancy rate per retrieval was 28 percent in good responders, 29 percent in poor responders, and 33 percent in luteal phase LA patients. Only one patient (0.4 percent) was hospitalized for severe ovarian hyperstimulation.

CONCLUSION

The flare-up protocol with high-dose human FSH and hMG is a very good alternative for patients who are at high risk for a poor response. Although peak E2 and number of oocytes were significantly lower in this group, the patients who responded had the same fertilization and pregnancy rate as the good responders. Cancellation rate remains high in poor responders.

摘要

目的

分析大剂量人促卵泡激素(FSH)联合人绝经期促性腺激素(hMG)及激发剂量醋酸亮丙瑞林(LA)方案对体外受精(IVF)时存在低反应风险患者的影响。

设计

前瞻性研究。

地点

独立的门诊IVF中心。

患者

284例患者接受了IVF的LA筛查试验。对缺乏激发反应的患者视为存在低反应风险,并采用激发剂量LA方案联合大剂量人FSH和hMG进行卵巢刺激。

结果

将低反应组与采用激发剂量LA方案的高反应组以及采用黄体期LA方案进行促排卵的患者进行比较。有53个低反应激发剂量LA周期、177个高反应激发剂量LA周期和54个黄体期LA周期。与高反应激发剂量LA组(1.1%)和黄体期LA周期组(1.8%)相比,低反应激发剂量LA组的取消率更高(11.3%)。高反应激发剂量LA组的雌激素峰值(E2)水平、卵母细胞数量和胚胎数量显著更高。所有组的受精率相似。每次取卵的持续妊娠率在高反应组为28%,低反应组为29%,黄体期LA组患者为33%。仅1例患者(0.4%)因严重卵巢过度刺激住院。

结论

大剂量人FSH和hMG的激发方案对于存在低反应高风险的患者是一个非常好的选择。尽管该组的E2峰值和卵母细胞数量显著较低,但有反应的患者与高反应者具有相同的受精率和妊娠率。低反应者的取消率仍然很高。

相似文献

1
Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.在低反应者体外受精中使用高剂量人卵泡刺激素和人绝经期促性腺激素的激发方案
Fertil Steril. 1996 Apr;65(4):796-9. doi: 10.1016/s0015-0282(16)58216-8.
2
Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a.体外受精项目中的临床妊娠率。在 GnRH-a 长方案失败后使用激发方案。
J Reprod Med. 2001 May;46(5):485-9.
3
Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.口服避孕药与促性腺激素释放激素激动剂联合抑制可改善高反应患者的体外受精结局。
Hum Reprod. 1997 Nov;12(11):2359-65. doi: 10.1093/humrep/12.11.2359.
4
The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization.亮丙瑞林筛查试验:在体外受精的卵巢刺激中调整醋酸亮丙瑞林的使用
Fertil Steril. 1991 Jul;56(1):79-83. doi: 10.1016/s0015-0282(16)54421-5.
5
Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.在接受 ICSI 的卵巢反应不良的女性中,使用来曲唑的微刺激方案与 GnRH 激动剂微剂量爆发方案的比较。
Gynecol Endocrinol. 2013 Feb;29(2):105-8. doi: 10.3109/09513590.2012.730569. Epub 2012 Nov 7.
6
[Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].国产高纯度尿促卵泡素对控制性卵巢刺激中体外受精-胚胎移植结局的影响
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):838-42.
7
Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization.
Fertil Steril. 1997 May;67(5):900-3. doi: 10.1016/s0015-0282(97)81403-3.
8
Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol.微剂量促卵泡激素激发联合生长激素方案改善体外受精低反应患者的控制性卵巢过度刺激
Fertil Steril. 1997 Jan;67(1):93-7. doi: 10.1016/s0015-0282(97)81862-6.
9
Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.对接受体外受精的反应不良者给予微剂量促性腺激素释放激素激动剂激发方案的临床及内分泌效应
Fertil Steril. 1998 Mar;69(3):419-24. doi: 10.1016/s0015-0282(97)00575-x.
10
Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?低反应者的管理:一种新型促性腺激素释放激素拮抗剂/来曲唑方案能否改善结局?
Fertil Steril. 2008 Jan;89(1):151-6. doi: 10.1016/j.fertnstert.2007.02.013. Epub 2007 May 4.

引用本文的文献

1
Ovarian Stimulation in Patient-oriented Strategies Encompassing Individualised Oocyte Number-4 Category; Antagonist versus Short-agonist Protocols.以患者为导向的策略中的卵巢刺激,包括个体化卵母细胞数量-4类别;拮抗剂方案与短效激动剂方案对比
J Hum Reprod Sci. 2023 Jul-Sep;16(3):212-217. doi: 10.4103/jhrs.jhrs_72_23. Epub 2023 Sep 29.
2
Meta-analysis of GnRH-antagonists versus GnRH-agonists in poor responder protocols.促性腺激素释放激素拮抗剂与促性腺激素释放激素激动剂在卵巢低反应患者方案中的荟萃分析。
Arch Gynecol Obstet. 2021 Aug;304(2):547-557. doi: 10.1007/s00404-020-05954-z. Epub 2021 Jan 10.
3
The appraisal of body content (ABC) trial: obesity does not significantly impact gamete production in infertile men and women.
评估身体成分(ABC)试验:肥胖症不会显著影响不孕男性和女性的配子产生。
J Assist Reprod Genet. 2020 Nov;37(11):2733-2742. doi: 10.1007/s10815-020-01930-3. Epub 2020 Aug 22.
4
Poor ovarian reserve.卵巢储备功能低下。
J Hum Reprod Sci. 2016 Apr-Jun;9(2):63-9. doi: 10.4103/0974-1208.183514.
5
Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy.对卵巢反应不良者的两种卵巢刺激方案的比较前瞻性研究:对种植率和持续妊娠的影响
Reprod Health. 2015 May 30;12:52. doi: 10.1186/s12978-015-0039-2.
6
Management of poor responders in IVF: is there anything new?体外受精中反应不良者的管理:有什么新进展吗?
Biomed Res Int. 2014;2014:352098. doi: 10.1155/2014/352098. Epub 2014 Jul 20.
7
The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization.芳香化酶抑制剂来曲唑用于促性腺激素释放激素拮抗剂多次给药方案对体外受精低反应者的影响。
Obstet Gynecol Sci. 2014 May;57(3):216-22. doi: 10.5468/ogs.2014.57.3.216. Epub 2014 May 15.
8
Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare -up protocol in poor responders: a preliminary study.超短效促性腺激素释放激素激动剂-拮抗剂方案与微刺激方案在低反应者中的比较:一项初步研究
J Turk Ger Gynecol Assoc. 2010 Dec 1;11(4):187-93. doi: 10.5152/jtgga.2010.35. eCollection 2010.
9
Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles.微剂量促性腺激素释放激素激动剂激发方案与超短效促性腺激素释放激素激动剂联合固定剂量促性腺激素释放激素拮抗剂在辅助生殖技术周期反应不良者中的应用比较
Int J Fertil Steril. 2013 Jan;6(4):266-71. Epub 2013 Mar 3.
10
Strategies for Pituitary Down-regulation to Optimize IVF/ICSI Outcome in Poor Ovarian Responders.垂体降调节策略以优化卵巢低反应者的体外受精/卵胞浆内单精子注射结局
J Reprod Infertil. 2012 Jul;13(3):124-30.